By Nicholas Abe, co-founder & COO of Boosted.ai How can investors get the best of both worlds from quantitative and fundamental approaches? By implementing machine learning...
The British AI drug development company Exscientia has raised $60 million in a Series C financing round. It was led by Denmark’s Novo Holdings, which is...
